Press Releases Bayer AG Deutsche Boerse AG

Equities

BAYN

DE000BAY0017

Market Closed - Deutsche Boerse AG Other stock markets 18:46:37 17/05/2024 BST			5-day change	1st Jan Change
28.58 ^EUR	-0.21%		-0.52%	-15.18%

05-17	BAYER AG : UBS remains Neutral	ZD
05-17	IQ-AI Unit Delivers Software to Insel Gruppe	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bayer : Q1 Media Update	05-14	PU
Bayer : First-quarter performance as expected	05-14	PU
Bayer : Address by Bill Anderson	04-26	PU
Bayer : Address by Bill Anderson	04-22	PU
Bayer : Explanations to the Supervisory Board Report - Prof. Dr. Norbert Winkeljohann	04-22	PU
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	04-17	EQ
Bayer - AskBio Names Mansuo Shannon Chief Scientific Officer	04-10	AQ
Bayer and Vividion Therapeutics to highlight advancing oncology portfolio at AACR 2024 Annual Meeting	04-04	AQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	04-03	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	03-27	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	03-22	EQ
Bayer Pharmaceuticals streamlines Leadership Team for next phase of growth	03-21	AQ
Bayer - Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer's elinzanetant	03-20	AQ
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing - Evogene	03-20	AQ
Bayer : Information in accordance with Section 125 of the German Stock Corporation Act (AktG) in conjunction with Article 4 and Annex Table 3 of the Commission Implementing Regulation (EU) 2018/1212	03-11	PU
Bayer : Letter from Norbert Winkeljohann, Chairman of the Supervisory Board, to our shareholders	03-10	PU
Bayer : Sample Registration Form	03-07	PU
Bayer : Control and Profit and Loss Transfer Agreement between Bayer Aktiengesellschaft and Bayer CropScience Aktiengesellschaft	03-07	PU
Bayer AG - BlueRock Therapeutics phase I clinical trial for Parkinson's disease continues to show positive trends at 18 months	03-07	AQ
Bayer : Curricula vitae of Jeffrey Ubben	03-06	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BAYER : As soft as anticipated

May 14, 2024 at 07:12 pm

Bayer AG: Not out of the woods yet

March 06, 2024 at 03:46 pm